Covance
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Innovative Trials opens first US office
Videos and Podcasts | August 1, 2022 | Innovative Trials
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...
Artificial Intelligence for Identifying and Monitoring Cognitive Decline
Videos and Podcasts | July 28, 2022 | Impetus Digital
Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.
OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital
Press Releases | July 28, 2022 | OPEN Health
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...
The Sofa Sessions – The First Page
Videos and Podcasts | July 27, 2022 | Page & Page Health
Be Patient
White Papers and Resources | July 27, 2022 | Page & Page Health
Awareness raising is key to boosting patient involvement and engendering trust.
Abstract Highlights from EHA 2022 : A Spotlight on CLL
Press Releases | July 26, 2022 | Medscape Education
Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...
Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma
Press Releases | July 26, 2022 | Medscape Education
Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...
Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic
White Papers and Resources | July 25, 2022 | Impetus Digital
While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...
TECHNOLOGY TRENDS AND THE FUTURE OF MEDICAL DEVICES
Press Releases | July 25, 2022 | Medscape Education
A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT
Meeting the experts behind the story: How building a bicycle led to a revolution in respiratory health
White Papers and Resources | July 25, 2022 | Say Communications
Hear from Professor Wladyslaw Wygnanski, inventor of a revolutionary respiratory medical device called BiMOD.